Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis

Somigliana E, Edgardo Somigliana, E Somigliana, P Viganò, Viganò P, Paola Viganò, G Rossi, Gabriele Rossi, Carinelli S, S Carinelli, Silvestro Carinelli, Vignali M, M. Vignali, Paola Panina‐Bordignon, P. Panina-bordignon
Human Reproduction · 1999 · vol. 14(12) , pp. 2944–2950 · doi:10.1093/humrep/14.12.2944 · PMID:10601076 · W2151735747
article OA: closed CC0 ⤵ 173 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

Interleukin-12 significantly reduced the size and surface area of ectopic endometrial implants in a murine model of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Immune dysfunctions in endometriosis are widely documented but the effectiveness of immunotherapies for the management of the disease is still debated. Progress in this field has also been limited by the lack of an appropriate animal model of the disease. In this study, we created a model of endometriosis in immunocompetent mice to verify the ability of endometrium to implant in ectopic sites and to investigate the potential application of the cytokine interleukin (IL)-12 in preventing this ectopic implantation. Endometriotic lesions were induced in both C57BL/6 and BALB/c mice by inoculating syngenic endometrial fragments through a small laparotomic incision into the peritoneal space. All the animals challenged with syngenic endometrium showed evidence of peritoneal endometriosis at 3 weeks. Histologically, endometriotic lesions consisted of cystic endometrial glands surrounded by a stroma. Intraperitoneal injection of IL-12 was able to reduce total weight and total surface area of endometriotic lesions respectively of 77 and 61% in C57BL/6 and of 42 and 28% in BALB/c mice. These results demonstrate that IL-12 is able to induce a significant prevention of ectopic endometrial implantation in an in-vivo model of endometriosis. These findings support the possibility of using the immune system to generate novel therapies for the management of the disease.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adjuvants, Immunologic Endometriosis Endometrium Interleukin-12 Adjuvants, Immunologic Animals Endometriosis Endometriosis Endometriosis Endometrium Endometrium Endometrium Female Interleukin-12 Mice Mice, Inbred BALB C Mice, Inbred C57BL

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (31)

Cited by (50)

Source provenance

europepmc
last seen: 2026-09-30T06:18:36.089610+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:10:24.024533+00:00
unpaywall
last seen: 2026-09-30T06:35:30.012611+00:00
License: CC0 · commercial use OK